35-usc-112a
2 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 20-380 | Idenix Pharmaceuticals LLC, et al. v. Gilead Sciences, Inc. | Federal Circuit | 2020-09-24 | Denied | Amici (3)Response RequestedResponse WaivedRelisted (2) | 35-usc-112a enablement genus-claim genus-claims patent patent-law pharmaceutical-innovation pharmaceuticals statutory-interpretation written-description | Whether the Federal Circuit's genus-claim-specific enablement rule and separate 'possession' requirement are consistent with 35 U.S.C. § 112(a) |
| 19-211 | Time Warner Cable, Inc., et al. v. Sprint Communications Company, L.P. | Federal Circuit | 2019-08-19 | Denied | Amici (1) | 35-usc-112 35-usc-112a 35-usc-284 apportionment federal-circuit garretson-v-clark patent-claims patent-damages patent-infringement patent-validity reasonable-royalty written-description | Whether the Federal Circuit erred by affirming a damages award based on unapportioned end-user service revenues |